Disc Medicine(IRON.US) Director Sells US$9,253.3 in Common Stock

$Disc Medicine(IRON.US)$ Director White William Richard sold 201 shares of common stock on Jul 1, 2024 at an average price of $46.0363 for a total value of $9,253.3.Source: Announcement What is statem

Futu NewsJul 4 04:57

Bitfarms Technologies, Vestis, and More Stocks See Action From Activist Investors -- Barrons.com

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequen

Barron'sJun 29 08:11

Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing

Mona Ashiya, Director, on June 17, 2024, executed a purchase for 83,334 shares in Disc Medicine (IRON) for $3,000,024. Following the Form 4 filing with the SEC, Ashiya has control over a total of 235,

MT NewswiresJun 21 05:32

Stifel Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $79

Stifel analyst Benjamin Burnett maintains $Disc Medicine(IRON.US)$ with a buy rating, and adjusts the target price from $72 to $79.According to TipRanks data, the analyst has a success rate of 35.3% a

Futu NewsJun 18 10:32 · Ratings

BMO Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Cuts Target Price to $50

BMO Capital analyst Evan Seigerman maintains $Disc Medicine(IRON.US)$ with a buy rating, and adjusts the target price from $70 to $50.According to TipRanks data, the analyst has a success rate of 47.4

Futu NewsJun 18 02:31 · Ratings

BMO Capital Reiterates Outperform on Disc Medicine, Raises Price Target to $70

BMO Capital analyst Evan Seigerman reiterates Disc Medicine (NASDAQ:IRON) with a Outperform and raises the price target from $50 to $70.

BenzingaJun 17 21:15